Skip to main content

Advertisement

Log in

Mixed corticomedullary adrenal carcinoma

  • Review Article
  • Published:
Surgery Today Aims and scope Submit manuscript

Abstract

Truly mixed corticomedullary tumors (MCMTs) are extremely rare and present as a single tumor mass composed of an intimately admixed population of both adrenal cortical cells and pheochromocytes. The current study describes the first case of a mixed corticomedullary adrenal carcinoma. In addition, we also review the published data on MCMTs to determine their clinical features, biochemical characteristics, pathological findings, and management. In order to compose this review, a search of the international literature for MCMTs was conducted. Fifteen related articles were found. The clinical and pathological information was obtained for all reported cases. MCMTs were found almost exclusively in females. In the vast majority of patients, the symptoms were related to the tumor’s hormone hypersecretion. Hypertension and diabetes were present in 80 and 40 % of cases, respectively. Cushing’s syndrome was reported in eight cases (53.33 %). A final diagnosis was made in all cases after surgery based on the pathological results. As of the writing of this article, all published cases of MCMTs had benign clinical behavior, with no instances of metastasis or death due to the tumor. MCMTs are currently considered to be benign tumors. Ours is the first case of malignant MCMT reported in the literature. The potential for malignancy should therefore be considered for these tumors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

Abbreviations

MCMT:

Mixed corticomedullary tumor

CT:

Computed tomography

MRI:

Magnetic resonance imaging

NSE:

Neuron-specific enolase

MCTC:

Mixed corticomedullary carcinoma

MeSH:

Medical subjected headings

References

  1. Bliss RD, Lennard TWJ. The adrenal glands in endocrine surgery. 3rd ed. Philadelphia: Elsevier Saunders; 2006. p. 80–103.

    Google Scholar 

  2. Singh M, Mandal S, Kakkar AK, Khurana N, Garg A. Mixed corticomedullary tumour with myelolipoma: a rare coexistence. Pathology. 2010;42:589–91.

    Article  PubMed  Google Scholar 

  3. Wieneke JA, Thompson LDR, Heffess CS. Corticomedullary mixed tumor of the adrenal gland. Ann Diagn Pathol. 2001;5:304–8.

    Article  PubMed  CAS  Google Scholar 

  4. Lau SK, Chu PG, Weiss LM. Mixed cortical adenoma and composite pheochromocytoma-ganglioneuroma: an unusual corticomedullary tumor of adrenal gland. Ann Diagn Pathol. 2011;15:185–9.

    Article  PubMed  Google Scholar 

  5. Alexandraki KI, Michail OP, Nonni A, Diamantis D, Giannopoulou I, Kaltsas GA, et al. Corticomedullary mixed adrenal tumor: case report and literature review. Endocr J. 2009;56:817–24.

    Article  PubMed  CAS  Google Scholar 

  6. Kimura T, Usui T, Inamoto S, Minamiguchi S, Okuno H, Sasano H, et al. Pheochromocytoma with subclinical Cushing’s syndrome caused by corticomedullary mixed tumor of adrenal gland. J Clin Endocrinol Metab. 2009;94:746–7.

    Article  PubMed  CAS  Google Scholar 

  7. Bonacci R, Gigliotti A, Baudin E, Wion-Barbot N, Emy P, Bonnay M, et al. Cytotoxic therapy with etoposide and cisplatin in advanced adrenocortical carcinoma. Br J Cancer. 1998;78:546–9.

    Article  PubMed  CAS  Google Scholar 

  8. Mathison DA, Waterhouse CA. Cushing’s syndrome with hypertensive crisis and mixed adrenal cortical adenoma-pheochromocytoma (corticomedullary adenoma). Am J Med. 1969;47:635–41.

    Article  PubMed  CAS  Google Scholar 

  9. Akai H, Sanoyama K, Namai K, Miura Y, Murakami O, Hanew K, et al. A case of adrenal mixed tumor of pheochromocytoma and adrenocortical adenoma presenting diabetes mellitus and hypertension (in Japanese with English abstract). Jpn J Endocrinol: Nihon NaibunpiGakkaiZasshi. 1993;69:659–69.

    CAS  Google Scholar 

  10. Chu AY, Livosli VA, Fraker DL, Zhang PJ. Corticomedullary mixed tumor of adrenal gland with concurrent adrenal myelolipoma. Arch Pathol Lab Med. 2003;127:329–32.

    Google Scholar 

  11. Delèvaux I, Cabane J, Picard O, Bénit C, Lebas J, Nordlinger B, et al. Mixed corticomedullary tumor. Presse Med. 1998;27:1272–4.

    PubMed  Google Scholar 

  12. Lee P, Bradbury RA, Sy J, Hughest L, Wong L, Falk G, et al. Phaeochromocytoma and mixed corticomedullary tumour—a rare cause of Cushing’s syndrome and labile hypertension in a primigravid woman postpartum. Clin Endocrinol. 2007;68:492–4.

    Google Scholar 

  13. Ma WY, Yang AH, Chang YH, Lin LY, Lin HD. Coexistence of adrenal Cushing syndrome and pheochromocytoma in a “corticomedullary adenoma”: a case report and review of the literature. Endocrinologist. 2007;17:341–5.

    Article  Google Scholar 

  14. Michal M, Havlicek F. Corticomedullary tumors of the adrenal glands. Report of two cases. Association of corticomedullary tumor with spindle cell sarcoma. Pathol Res Pract. 1996;192:1082–9.

    Article  PubMed  CAS  Google Scholar 

  15. Trimeche Ajmi S, Chadli Chaieb M, Mokni M, Braham R, Ach K, Maaroufi A, et al. Corticomedullary mixed tumor of the adrenal gland. Ann Endocrinol (Paris). 2009;70:473–6.

    Article  CAS  Google Scholar 

  16. Ohta TI, Motoyama T, Imai T, Komeyama T, Watanabe H. Cortico-medullary mixed tumor (Pheochromocytoma and cortical adenoma) of the adrenal gland. J Urol Pathol. 1995;3:157–64.

    Google Scholar 

  17. Hu WL, Cao QY, He HX, L J, Li QR, Wang YL, et al. Misdiagnosis of corticomedullary mixed pathological changes in adrenals: report of 4 cases. Di Yi Jun Yi Da Xue Xue Bao. 2002;22:1145–7.

    Google Scholar 

  18. Li ZL, Sun D, Kong CZ. Diagnosis and treatment for the corticomedullary mixed tumor of adrenal gland. ZhonghuaWai Ke Za Zhi. 2009;47:1239–41.

    Google Scholar 

  19. Sangoi A, McKenney J. A tissue microarray-based comparative analysis of novel and traditional immunohistochemical markers in the distinction between adrenal cortical lesions and pheochromocytoma. Am J Pathol. 2010;34:423–32.

    Article  Google Scholar 

  20. Stachowiak MK, Rigual RJ, Lee PHK. Regulation of tyrosine hydroxylase and phenylethanolamine N-methyltransferse mRNA levels in the sympathoadrenal system by the pituitary–adrenocortical axis. Brain Res. 1998;427:275–86.

    Google Scholar 

  21. Ehrhart-Bornstein M, Hinson JP, Bornstein SR, Scherbaum WA, Vinson GP. Intraadrenal interactions in the regulation of adrenocortical steroidogenesis. Endocr Rev. 1998;19:101–43.

    Article  PubMed  CAS  Google Scholar 

  22. Schinner S, Bornstein SR. Cortical-chromaffin cell interactions in the adrenal gland. Endocr Pathol. 2005;16:91–8.

    Article  PubMed  CAS  Google Scholar 

  23. Andersen KF, Altaf R, Krarup-Hansen A, Kromann-Andersen B, Horn T, Christensen NJ, et al. Malignant pheochromocytomas and paragangliomas—the importance of a multidisciplinary approach. Cancer Treat Rev. 2011;37:111–9.

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

All authors declare that there is no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Nick Michalopoulos.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Michalopoulos, N., Pazaitou-Panayiotou, K., Boudina, M. et al. Mixed corticomedullary adrenal carcinoma. Surg Today 43, 1232–1239 (2013). https://doi.org/10.1007/s00595-012-0458-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00595-012-0458-4

Keywords

Navigation